Synsight Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
Synsight General Information
Description
Developer of a drug discovery platform designed to combine artificial intelligence, molecular modeling and functional content screening. The company's platform specializes in molecular modeling, bioinformatics and structural biology to secure and efficiently new molecules, enabling clients to improve and accelerate their research.
Contact Information
Website
www.synsight.netCorporate Office
- 4 Rue Pierre Fontaine
- 91058 Evry
- France
Corporate Office
- 4 Rue Pierre Fontaine
- 91058 Evry
- France
Synsight Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 08-Jul-2024 | Completed | Generating Revenue | |||
| 4. Seed Round | 29-Mar-2022 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 06-Jul-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Mar-2013 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Synsight Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
Synsight Comparisons
Industry
Financing
Details
Synsight Competitors (5)
One of Synsight’s 5 competitors is AQEMIA, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AQEMIA | Venture Capital-Backed | Paris, France | ||||
| Iktos | Venture Capital-Backed | Paris, France | ||||
| Kvantify | Venture Capital-Backed | Copenhagen, Denmark | ||||
| Ariana Pharma | Formerly VC-backed | Paris, France | ||||
| POLARISqb | Venture Capital-Backed | Durham, NC |
Synsight Signals
Synsight Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator | |||
| Health Innovation Hub | Accelerator/Incubator | |||
| IncubAlliance | Accelerator/Incubator | Minority | ||
| University of Toronto | University |
Synsight FAQs
-
When was Synsight founded?
Synsight was founded in 2013.
-
Where is Synsight headquartered?
Synsight is headquartered in Evry, France.
-
What is the size of Synsight?
Synsight has 8 total employees.
-
What industry is Synsight in?
Synsight’s primary industry is Drug Discovery.
-
Is Synsight a private or public company?
Synsight is a Private company.
-
What is Synsight’s current revenue?
The current revenue for Synsight is .
-
How much funding has Synsight raised over time?
Synsight has raised $1.83M.
-
Who are Synsight’s investors?
Bpifrance, Creative Destruction Lab, Health Innovation Hub, IncubAlliance, and University of Toronto are 5 of 6 investors who have invested in Synsight.
-
Who are Synsight’s competitors?
AQEMIA, Iktos, Kvantify, Ariana Pharma, and POLARISqb are competitors of Synsight.
-
When was Synsight acquired?
Synsight was acquired on 08-Jul-2024.
-
Who acquired Synsight?
Synsight was acquired by Iktos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process